companies > A > AstraZeneca AstraZeneca AstraZeneca says its new anti-clotting drug better than Plavix 31 August 2009 AstraZeneca, Merck & Co to in phase 1 cancer drug research 01 June 2009 Jubilant signs research deal with Anglo-Swedish firm AstraZeneca 06 May 2009 Infosys wins multi-million dollar AstraZeneca deal 15 December 2008 AstraZeneca, Abraxis rethink cancer drug deal 26 November 2008 AstraZeneca agrees to cut drug prices in UK, stock plummets 20 November 2008 Fish oil better than AstraZeneca's Crestor says new heart-failure study 01 September 2008 US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel 03 July 2008 Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US 15 April 2008 AstraZeneca forms clinical research venture with private equity firms 18 February 2008 AstraZeneca acquires paediatric asthma development programmes from Verus Pharmaceuticals 25 September 2007 AstraZeneca to acquire US biotech firm MedImmune for $15.6 billion 28 April 2007 Global collaboration to develop new anti-obesity compounds 02 February 2007 Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement 24 November 2005 AstraZeneca sues Ranbaxy on Nexium patent 22 November 2005 AstraZeneca to drop Viozan 29 June 2001 AstraZeneca launches $ 100 million facility in China 30 April 2001 AstraZeneca to acquire development rights from Cyclacel 17 April 2001 AstraZeneca sells off speciality chemicals 13 May 1999 Cheminor unfazed by AstraZeneca patent infringement suit 13 May 1999  search domain-b    go
Legal Policy | Copyright © 1999-2009 The Information Company Private Limited. All rights reserved.